Skip to main content
Premium Trial:

Request an Annual Quote

DOE Seeks Applicants For Instrumentation Research Grants


WASHINGTON--The Office of Biological and Environmental Research of the Office of Energy Research of the U.S. Department of Energy, announced that it is accepting applications in instrumentation research supporting the Human Genome Program. The department seeks applications from a broad range of scientists with backgrounds in biology, chemistry, physics, or engineering, including those not presently involved in the Human Genome Program.

To meet the needs of biology in the next century, the department seeks research in new instrumentation and technical approaches for DNA sequencing, automation and integration of DNA sequencing systems, validation of DNA sequencing accuracy, and the determination of gene function of newly sequenced DNA. The goals are to reduce costs and increase throughput while maintaining accuracy for producing DNA sequences and related analyses.

Preapplications should be received by DOE by June 8, and formal applications must be received by August 19. More information is available at

Filed under

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.